Pharma Focus Europe

27/05/2026

The future of Europe’s pharmaceutical industry is being shaped by innovation, technology, and industry leadership.

Pharma Focus Europe brings together the latest pharma trends, expert insights, biotech advancements, and healthcare intelligence that matter to decision-makers across the life sciences ecosystem.

From manufacturing transformation to precision medicine and AI-powered healthcare solutions, stay connected with the conversations driving the next phase of pharmaceutical growth.

🌍 Join a growing network of pharma professionals and industry leaders.

👉 Visit us today: https://tinyurl.com/mrxdcwsx

26/05/2026

European pharma is entering a new era of innovation, collaboration, and industry transformation.

From breakthrough research to smart manufacturing and digital health solutions, the pharmaceutical industry continues to redefine the future of healthcare.

Pharma Focus Europe delivers the latest insights, expert opinions, and emerging trends helping pharma leaders, researchers, and healthcare professionals stay informed and connected.

✨ Stay updated with the ideas shaping the future of pharma.

👉 Visit now: https://shorturl.at/yJdrn

25/05/2026

💡 Smarter quality starts with connected systems.

See how the Tri-Integrity Approach helps pharma manufacturers unify QMS, MES & LIMS for better visibility, compliance, and operational excellence.

Download Now: https://www.pharmafocuseurope.com/promotion/yokogawa-tri-integrity-quality-whitepaper

Discover how the Tri-Integrity approach is transforming modern manufacturing into a connected, intelligent, and quality-driven ecosystem....

25/05/2026

The pharmaceutical industry is evolving faster than ever. From AI-driven research to smarter manufacturing and digital health transformation, innovation is changing how therapies are developed and delivered worldwide.

Pharma Focus Europe shares expert perspectives, biotech trends, research developments, and pharmaceutical insights designed for today’s healthcare leaders.

Stay informed with the latest advancements shaping the future of pharma and life sciences: https://tinyurl.com/43r2db83

21/05/2026

Quality failures don’t just create compliance issues — they can directly impact business growth and patient confidence.

In this insightful conversation, Barbara Glantschnig, SVP Global Quality, Plasma-Derived Therapies at Takeda, shares how pharma organizations can strengthen quality systems through smart risk management, digital tools, contamination control strategies, and proactive leadership.

The interview also explores the growing complexity of ATMPs and plasma-derived therapies, where maintaining operational reliability and meeting evolving regulatory expectations are becoming more critical than ever.

Forward-thinking pharma companies are transforming quality from a functional obligation into a long-term business advantage.

Visit our website to read the complete interview and industry insights: https://www.pharmafocuseurope.com/expert-talk/make-quality-a-strategic-business-driver

20/05/2026

🚀 Smarter manufacturing starts with smarter quality management.

Learn how the Tri-Integrity Approach integrates QMS, MES & LIMS to improve:
✅ Data integrity
✅ Operational visibility
✅ Compliance & efficiency
✅ Continuous improvement

Explore the future of Quality 4.0 in this exclusive whitepaper.

Download your free copy:
https://www.pharmafocuseurope.com/promotion/yokogawa-tri-integrity-quality-whitepaper

20/05/2026

🧬 The future of Cell & Gene Therapy will be built on collaboration, agility, and scalable innovation.

According to Chaozhong Zou of Cincinnati Children's, the next phase of CGT is being shaped by advances in multi-target immunotherapies, armored cell designs, and point-of-care manufacturing — especially for rare diseases and autologous therapies.

While innovation continues at an impressive pace, the industry still faces pressing challenges around manufacturing complexity, therapy accessibility, and regulatory alignment.

One of the strongest shifts happening today is the increasing reliance on CDMO partnerships to support specialized development, flexible capacity, and commercialization readiness.

📢 Do you agree with this perspective?
Explore the full insight, cast your vote—agree, Neutral, or disagree—and share your feedback under the author’s perspective.

Read more here: https://www.pharmafocuseurope.com/pharma-industry-insights/chaozhong-zou

19/05/2026

Advanced therapies are reshaping medicine — and redefining how the industry approaches long-term safety.

In this expert discussion, Vasudev Bhupathi, Director, Pharmacovigilance at Moderna, explains why proactive pharmacovigilance and lifecycle safety monitoring are becoming essential for emerging therapies like gene therapy and immuno-oncology platforms.

The article explores:
🔹 Delayed and late-onset toxicities
🔹 AI-powered safety monitoring
🔹 Real-world evidence in long-term safety evaluation
🔹 Regulatory expectations for advanced therapies
🔹 Balancing innovation with patient safety

As therapies become more complex, long-term monitoring is becoming just as important as clinical innovation itself.

Visit our website to read the complete expert perspective and stay informed on the future of advanced therapeutic safety strategies: https://www.pharmafocuseurope.com/expert-talk/long-term-safety-of-emerging-combination-therapies

18/05/2026

📊 What truly drives high-performance technical teams in pharma?

According to Dr. Kishore Kumar Hotha, it’s not just expertise — it’s the ability to learn faster, adapt faster, and solve problems earlier.

Across innovator pharma, CDMOs, and contract testing labs, the operating models may differ, but the winning principles remain the same:

🔹 Surface issues early
🔹 Build a culture of trust and feedback
🔹 Keep leaders connected to the science and data
🔹 Prevent knowledge silos across teams
🔹 Balance experimentation with GMP compliance

⚠️ One of the most powerful takeaways:
“Data integrity failures are often system failures disguised as moral failures.”

This expert discussion offers practical strategies for building resilient teams, improving technical reviews, and creating a stronger quality culture across pharmaceutical operations.

👉 Visit our website to read the complete interview: https://www.pharmafocuseurope.com/expert-talk/learning-faster-than-the-problem-building

15/05/2026

📢 Attention pharma professionals, researchers, and decision-makers.

Pharma Focus Europe has just released its latest email newsletter—and it's packed with value.

Inside this edition:
✔️ Exclusive interviews with industry leaders
✔️ Techno trends shaping drug development
✔️ New industrial projects & press releases
✔️ Latest research insights & podcasts
✔️ The newest digital magazine

Whether you're in R&D, manufacturing, or executive strategy—this keeps you informed.

Subscribe now via the link below. Share this post with your colleagues and connections so they don't miss out: https://www.pharmafocuseurope.com/e-newsletter-subscribe

👉https://industry.pharmafocuseurope.com/e-newsletters/1778669147-Pharma-Focus-Europe-May-26.html